Relaxin: Additional Phase II/III data

Additional data from the double-blind, international Phase II Pre-RELAX-AHF trial in 229 patients showed that 30 µg/kg/day IV relaxin improved dyspnea at 6, 12 and 24 hours as measured by the Likert s...